About Us
About Us
Stock Code 603229
About Us
Zhejiang Ausun Pharmaceutical Co., Ltd.
AUSUN PHARM is based in the Taizhou Bay Economic and Technological Development Zone, Zhejiang Province,and a national-level Intellectual Property Advantage Enterprise recognized by National Intellectual Property Administration, P.R.C. Currently, AUSUN PHARM has established a national postdoctoral workstation, Zhejiang Provincial Key Enterprise Research Institute, Provincial Enterprise Technology Center, Provincial R&D Center, and other platforms. It has more than 1,000 employees and a research and development and analysis team of over 400 people composed of doctors, masters, and others.
Company Established
Current Employees
Global Partners
Service Cities
Group Culture
Core Corporate Values: "Unity, Diligence, Pragmatism, Innovation, Integrity in Conduct and Work, Giving Back to Society"
Company Culture
Our culture is built on shared principles that guide how we work, collaborate, and contribute to society.
Company Values
Integrity
We conduct our business with honesty, transparency, and accountability.
Purposeful Innovation
We strive to develop meaningful solutions that advance healthcare and improve patients’ lives.
Collaboration
We foster respectful partnerships and teamwork, working together to achieve common goals.
Shared Success
We are committed to creating long lasting value for our customers, employees, partners, and stakeholders.
Development History
Year 2025
Passed China GMP compliance inspection
Passed Brazilian official audit
Year 2024
Passed EU GMP audit
Passed FDA audit
Passed South Korean official audit
Founded: June,2024
Total Area: 176,000m²
Phase I Construction Area: 59,950 m²
Construction start date: November 2025
Address: Linhai，Taizhou,Zhejiang, China
Year 2023
Passed China GMP compliance inspection
Passed Japan PMDA audit
Approved as Zhejiang Province Science and Technology Little Giant Enterprise
Provincial-level Invisible Champion Enterprise
Recognized as a high-growth enterprise in the biopharmaceutical industry
Year 2022
Passed China GMP compliance inspection
Passed Japan PMDA audit
Recognized as a key provincial research institute in Zhejiang
Approved as a national-level intellectual property advantage enterprise
Zhejiang Province intellectual property demonstration enterprise
Year 2021
Company passed China's GMP compliance inspection
First intellectual property management system certification
Qi Zheng formulation project trial production started
Year 2020
Passed China GMP compliance inspection
Passed Russian audit
National-level postdoctoral research workstation
Year 2019
Certified by China GMP
2018
Passed the US FDA audit again
2017
Listed on the Shanghai Stock Exchange
2016
Audited by PMDA
2015
AUSUN PHARM submitted an application for listing
Established a postdoctoral workstation and a provincial-level enterprise research institute
2014
First audit by the U.S. FDA
First ISO 14001 standard certification
First occupational health and safety standard 18001
Signed technology transfer agreement for a Class I new drug BZP for stroke treatment with Zhengzhou University
Established Zhejiang Provincial Academician Expert Workstation and High-tech Enterprise Research and Development Center
Year 2013
Recognized as a National High-Tech Enterprise;
Passed the EU GMP audit for the first time
2012
AUSUN PHARM's first workshop has started production.
Year 2010
AUSUN PHARM Pharmaceutical Established
AUSUN PHARM established the first academician and expert workstation in Taizhou City
Corporate Responsibility
AUSUN PHARM focuses on making conscientious, reliable, and effective medicine!
As a specialized enterprise, AUSUN PHARM is a health messenger serving consumer health.
Conscientiousness: AUSUN PHARMFirst; Professionalism: Becoming Experts in Medicine Making.
Email:
Company Address:
No.5, Donghai 4th Avenue, Zhejiang Chemical Materials Base Linhai Zone, Taizhou,Zhejiang,China
